Yahoo Web Search

Search results

1. • FDA leaders talk adcomms, shortages

     Politico· 9 hours ago

     David’s Califf bingo card was quite popular this week among senior FDA officials and other attendees of the FDLI conference. Send news and tips to David Lim ([email protected ...

2. • 

     BLUE vs. CRSP: Why Are These Stocks Moving in Opposite Directions?

     TipRanks via Yahoo Finance· 5 hours ago

     Last week, Bluebird Bio (NASDAQ:BLUE) shares climbed while CRISPR Therapeutics (NASDAQ:CRSP) stock...

3. • Could Stem Cells One Day Cure Diabetes? - Slashdot

     Slashdot· 6 days ago

     Brian Shelton's type 1 diabetes was treated with an infusion of insulin-producing pancreas cells (grown from stem cells). In 2021, the New York Times reported: Now his body ...

4. • Research explains new method to engineer immune cells that could treat multiple cancer patients

     Medical Xpress· 1 day ago

     This novel technology, described in a study published in Nature Biotechnology, marks a major step toward enabling the mass production of cell therapies like CAR-T

5. • BrainStorm Cell Therapeutics Announces First Quarter 2024 Financial Results and Provides Corporate...

     WKRN Nashville· 3 days ago

     BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell therapeutics for neurodegenerative diseases, ...

6. • Food & Beverage Litigation and Regulatory Update - May 2024 | JD Supra

     JD Supra· 18 hours ago

     The U.S. Food and Drug Administration (FDA) reportedly found per- and poly-fluoroalkyl substances (PFAS) in eight of 95 foods tested for the so-called “forever chemicals.” ...

7. • 

     Sickle cell anemia treatment: Medications and more

     Medical News Today· 2 days ago

     Sickle cell anemia is the most severe form of sickle cell disease (SCD). Treatments for sickle cell anemia include medications, blood ...

8. • 

     Karius snares FDA breakthrough tag for genomic infectious disease blood test

     FierceBiotech· 2 days ago

     After picking up $100 million in venture capital cash earlier this month, Karius is adding another...

9. • BioRestorative Therapies (NASDAQ:BRTX) Announces Commercial Agreement With Cartessa, Further...

     Digital Journal· 3 days ago

     The ultimate goal is to obtain approvals from the U.S. Food and Drug Administration (FDA) in the emerging bio-cosmeceuticals field. Under the terms of this exclusive five-year ...

10. • FDA Publishes Final Rule on Regulation of Lab-Developed Tests | JD Supra

      JD Supra· 5 days ago

      On May 6, 2024 the FDA published its much-anticipated Final Rule1 on Lab-Developed Tests (“LDTs”) to make explicit that in vitro diagnostic products (“IVDs”) are devices under ...